TCTMD

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Initial data looking at safety and efficacy of an interatrial septal occluder with a bioresorbable frame show promise for closing atrial septal defects (ASDs), but the study authors suggest a redesign ...
Science Daily

Device achieves 90 percent closure rate for atrial septal defect in children; Biodegradable implant avoids risks associated with metal devices

A novel study by Canadian physicians reported that the BioSTAR biodegradable implant achieved comparable closure rates to the Amplatzer Septal Occluder in children with atrial septal defect. A novel ...
Medscape

Contemporary Clinical Management of Atrial Septal Defects in the Adult

Expert Rev Cardiovasc Ther. 2007;5(6):1135-1146. Diagnosing a secundum ASD is more often than not incidental because the defect normally causes symptoms late in adult life. Echocardiography and MRI ...
Medscape

ASD occluder used to close left atrial appendage

Bern, Switzerland - In an unorthodox procedure, Dr Bernhard Meier (Swiss Cardiovascular Center Bern, University Hospital Inselspital) has used a device designed to close atrial-septal defects (ASD) to ...
TCTMD

TCT 1300: Double Atrial Septal Defect of Challenging Sizing: Closure With a Single Device Under Multi-Modality Imaging Guidance (3D-ICE and Micro-TEE)

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Business Wire

Growth of Heart Defect Closure Devices Market to be Impacted by the Use of 3D Imaging in Heart Defect Closure Procedures | Technavio

LONDON--(BUSINESS WIRE)--The report, heart defect closure devices market 2019-2023, has been added to Technavio's catalog. It provides a comprehensive analysis of the market, including its global and ...